CyADA - Cyprus Anti-Doping Authority

Starting in 2011, athletes are no longer obligated to file a Declaration of Use [as it was required for some beta-2 agonists (S3), specific routes of administration of glucocorticosteroids (S9), and PRPs (S2)]. This change is reflected in the 2011 International Standard for Therapeutic Use Exemptions.

Athletes should now declare all medications and supplements used on the doping control form if selected for Doping Control.

Α Therapeutic Use Exemption is required whenever an athlete requires the use of  prohibited substances and prohibited method.